Peptidomimetic antagonists of αvβ3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.

Autor: Carron, C. P., Meyer, D. M., Engleman, V. W., Rico, J. G., Ruminski, P. G., Ornberg, R. L., Westlin, W. F., Nickols, G. A.
Zdroj: Journal of Endocrinology; Jun2000, Vol. 165 Issue 3, p587-598, 12p
Databáze: Complementary Index